THCV vs CBD: What Actually Differs
CBD is the cannabinoid with a prescription medicine to its name; THCV is the one sold as "diet weed". Only CBD reliably stays non-intoxicating, because THCV's action at CB₁ changes with dose. CBD also has far more human research behind it, while THCV's appetite claim has no primary evidence in a person. Demonstrated · in vitro
Grades follow the evidence behind each statement. Legal notes are general and dated, and they are not legal advice; this page makes no therapeutic claim for either compound.
Side by side
| Attribute | THCV (tetrahydrocannabivarin) | CBD (cannabidiol) |
|---|---|---|
| Intoxicating? | THCV (tetrahydrocannabivarin)Cannot be relied on as non-intoxicating; depends on dose (Pertwee 2008) · Demonstrated · in vitro | CBD (cannabidiol)No · Established |
| Where it comes from | THCV (tetrahydrocannabivarin)The propyl ("varin") relative of THC | CBD (cannabidiol)Made from CBDA, an acid the plant builds from CBGA on a branch of its own |
| Molecular formula | THCV (tetrahydrocannabivarin)C₁₉H₂₆O₂ (CAS 31262-37-0) | CBD (cannabidiol)C₂₁H₃₀O₂ (CAS 13956-29-1) |
| Human evidence | THCV (tetrahydrocannabivarin)No primary evidence in our registry that THCV changes appetite or body weight in a person · No primary evidence | CBD (cannabidiol)Studied far more in people. CBD is the active ingredient in an approved prescription medicine for certain rare seizure disorders; that is a regulatory fact, not a claim about consumer CBD products · Established |
| Drug testing | THCV (tetrahydrocannabivarin)Tests screen for THC, not THCV. Many THCV products contain trace THC, and how THCV itself behaves on a test has not been characterised · Established | CBD (cannabidiol)Tests screen for THC, not CBD, though many CBD products contain trace THC · Established |
| US legal status (general, dated; not legal advice) | THCV (tetrahydrocannabivarin)Less clear-cut: tied to the 2018 Farm Bill and to total-THC rules that are still changing; differs by state | CBD (cannabidiol)Hemp-derived CBD at ≤0.3% Δ⁹-THC is generally federally legal under the 2018 Farm Bill; differs by state |
- How to read a cell
- An oxblood ring holds the direction: a bar: blocks; a chevron: activates; a chevron with a bar: activates, then desensitises; two bars: damps activation. A gold ring with a dot: recorded in a review, direction qualified by the source, no rung of its own. A dashed frame: no graded interaction in our registry.
- CB1 cannabinoid receptor
- THCV: blocks, and at higher doses activates (direction reverses with dose), in a review, no rung of its own study type: Review Pertwee 2008. CBD: damps activation (negative allosteric modulator; drawn as two bars), in vitro grade: Demonstrated study type: In vitro Laprairie 2015.
- CB2 cannabinoid receptor
- THCV: activates (partial agonist; an earlier paper reports the opposite), in a review, no rung of its own study type: Review Pertwee 2008. CBD: blocks what activates it (antagonist of CB1/CB2 agonists), in a review, no rung of its own study type: Review Pertwee 2008.
- α2-adrenoceptor
- THCV: no graded interaction in our registry. CBD: no graded interaction in our registry.
- 5-HT1A serotonin receptor
- THCV: no graded interaction in our registry. CBD: activates (agonist; drawn as a chevron), in vitro grade: Demonstrated study type: In vitro Russo 2005.
- TRPV1 and TRPV2 ion channels
- THCV: no graded interaction in our registry. CBD: no graded interaction in our registry.
- TRPM8 ion channel
- THCV: no graded interaction in our registry. CBD: no graded interaction in our registry.
What the evidence settles
Start with the question a formulator has to answer before any other: will the product get someone high?
- Intoxication. CBD stays non-intoxicating. THCV's answer depends on how much of it is in the bottle. In living animals it acts as a CB₁ antagonist, or as a CB₁ agonist at higher doses, and nobody has established the human dose at which that switch happens (Pertwee 2008). A blanket "non-intoxicating" label on a THCV product is therefore resting on air. Demonstrated · in vitro
- Different families. The split starts in the plant. THCV (C₁₉H₂₆O₂) is the three-carbon "varin" relative of THC, while CBD (C₂₁H₃₀O₂) is made from CBDA. Established
- Different receptor profiles. Lab studies show the two compounds working on different sets of receptors (Pertwee 2008; De Petrocellis 2011). Demonstrated · in vitro
- CBD in people. Here CBD pulls well ahead, with human research that far outweighs THCV's. CBD is also the active ingredient in an approved prescription medicine for certain rare seizure disorders, a regulatory fact that says nothing about consumer CBD products. Established
- THCV and appetite. The "diet weed" tag is THCV's biggest selling point and its weakest: our registry holds no primary evidence that it changes appetite or body weight in a person. No primary evidence
Common questions
Does THCV or CBD get you high?
CBD doesn't; THCV depends on the dose. In laboratory studies THCV blocks CB₁, but in living animals it can activate CB₁ at higher doses (Pertwee 2008). Nobody has established the human dose for that switch, so a THCV product sold as non-intoxicating at every amount is making a promise the research can't back. Demonstrated · in vitro
Is THCV or CBD better for appetite or weight loss?
Neither has been shown to work for appetite or weight loss. THCV carries the "diet weed" marketing, yet our registry holds no primary evidence that it changes appetite or body weight in a person. We make no appetite claim for CBD either, and neither is an approved weight-loss product. (Not medical advice.) No primary evidence
Which has more human evidence, THCV or CBD?
CBD, by a wide margin. It has been studied far more in people, and it is the active ingredient in an approved prescription medicine for certain rare seizure disorders, though that approval is a regulatory fact rather than a claim about consumer CBD products. THCV's best-known claim, appetite, has no primary evidence in our registry. Established
Can you take THCV and CBD together?
Some products already combine them, though no controlled human study has shown the pairing doing more than either compound alone. Dose matters here too, given how THCV shifts with it. If you take other medicines, ask a clinician. (Not medical advice.) No primary evidence
Will THCV or CBD show up on a drug test?
Neither is the target; standard tests screen for THC and its metabolites. The danger is the trace THC that many THCV and CBD products carry. THCV adds a second unknown: how it behaves on a test remains poorly characterised, so a pass can't be taken for granted. Established
Are THCV and CBD legal?
Often yes in the US, with caveats. The 2018 Farm Bill generally makes hemp-derived CBD at ≤0.3% Δ⁹-THC federally legal. THCV stands on shakier ground, tied up in total-THC rules that are still changing, and each state writes its own. General information, not legal advice. [Legal snapshot · not legal advice]
Informational only — not our claims, and not advice. The statements on this page about potential effects, benefits, or uses reflect claims made by third parties (manufacturers, media, traditional use, or preliminary research) and are presented for educational and informational purposes only. CBG Atlas does not make, adopt, endorse, or affirm these claims, and does not represent them as fact. These statements have not been evaluated by the Food and Drug Administration (or any regulator) and are not intended to diagnose, treat, cure, or prevent any disease. Nothing here is medical, legal, or professional advice; cannabinoid effects, safety, and legal status vary by person, product, and jurisdiction and can change over time. Consult a qualified professional before making any health or purchasing decision. Where we can, we show how strong the evidence is and cite the source; where evidence is thin or absent, we say so. Peregrine Biopharma funds the platform and holds no editorial authority.
Sources
- Pertwee et al. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. PMID 17828291.
- De Petrocellis et al. (2011). Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. PMID 21175579.
Before you act on what you have read
Informational only, not medical advice. CBG Atlas is a scientific reference. Nothing here diagnoses, treats, cures or prevents any disease. Every claim on the page carries the grade of the evidence behind it, and the grade sets the words the claim may use. How we grade evidence.
Each grade rates the support for a claim across the literature. It does not rate any single study. An effect in cells may never show up in people. The grades cover the studies checked up to 9 August 2026. This page is for information and is not medical advice.
Cardiovascular note. CBG is a potent α2-adrenoceptor agonist in vitro, and α2 agonism can lower blood pressure. Anyone taking blood-pressure or other cardiovascular medication should consult a clinician before use. This is educational information, not medical advice.
Funding and independence. Peregrine Biopharma funds the platform and holds no editorial authority.
Report a safety event →Keep exploring
The compounds compared
More comparisons